NIH to Cap Publishing Fees for Publicly Funded Research

Follow Drugslib on

By Stephanie Brown HealthDay Reporter

Medically reviewed by Drugs.com

via HealthDay

WEDNESDAY, July 9, 2025 -- The National Institutes of Health announced it will put a limit on publisher fees for publicly funded research by Fiscal Year 2026.

According to the NIH, some publishers of top medical journals charge as much as $13,000 per article for immediate open access. The publishers of these journals also collect what the NIH calls "substantial" subscription fees from government agencies. The NIH contends that these fees place an additional burden on taxpayers as their taxes have already funded the underlying research.

The exact limit on allowable publication charges was not provided. The NIH says it hopes the policy will guarantee publication fees remain reasonable across the board. With this policy, NIH aims to "curb excessive article processing charges and ensure the broad dissemination of research findings without unnecessary financial barriers."

"This policy marks a critical step in protecting the integrity of the scientific publishing system while ensuring that public investments in research deliver maximum public benefit," NIH Director Jay Bhattacharya, M.D., said in a statement.

Other agency initiatives include making NIH-funded published research available free of charge and without embargo; timely sharing of scientific data regardless of publication status; providing insight into NIH-funded research activities and results; and encouraging use of NIH-developed technologies through licensing strategies that improve access.

More Information

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2025-07-10 12:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords